BALPHARMA.BOBALPHARMA.BOBSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank80
3Y CAGR-5.0%
5Y CAGR+1.6%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-5.0%/yr
vs +4.6%/yr prior
5Y CAGR
+1.6%/yr
Recent deceleration
Acceleration
-9.6pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.08B+47.4%
2025$730.18M-5.2%
2024$770.20M-38.6%
2023$1.25B+12.5%
2022$1.11B+12.3%
2021$993.03M+16.2%
2020$854.90M-18.3%
2019$1.05B-2.3%
2018$1.07B-4.2%
2017$1.12B-